Leveraging Real-world Insights to Inform Patient-Centered Care: Modern JAKi Strategies in Individualized Myelofibrosis Management

Learn more about leading experts’ practical approaches to optimizing JAK inhibitor therapy for patients with myelofibrosis and gain valuable insights to enhance your patients’ outcomes by tailoring treatments to meet individual needs in myelofibrosis care.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from CTI BioPharma Corp., a Sobi Company; and Incyte Corporation.

CTI BioPharma Corp., a Sobi Company

Incyte Corporation